Key Drivers
- Margin Expansion
- Cash Flow Rebound
- Loss History
AIAI Summary
Clover Health now looks like a credible profitability turnaround—not just a growth story—after 48% Medicare Advantage membership growth, positive GAAP earnings, and positive free cash flow, but the key takeaway is to stay cautious until several more quarters confirm that margin expansion and medical-cost discipline can hold as it scales.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Cash Flow Rebound
- •Loss History
CLOV's latest quarter showed a clear turnaround with margins and cash flow turning positive, strong liquidity, and no debt, but the business still carries a large cumulative deficit and must prove the improvement is sustainable.
Price Behavior
Key Price Behavior Insights:
- •Flat Trend
- •Strong Rebound
- •Range Bound
CLOV has been flat over the last month, with a rebound from early-August lows forming support in the low $4s but repeated failures in the mid-to-high $4.7s keeping the setup neutral until a breakout.
Sharp rebound from the 2026-08-05 low through 2026-08-07 after a pullback suggests volatility risk
Sentiment & News
Key News Insights:
- •MA Growth
- •Margin Expansion
- •Raised Guidance
Clover Health is showing strong Medicare Advantage growth and improving profitability, with raised 2026 guidance and technology-driven momentum outweighing a limited cyber incident and small insider sale.
The stronger-than-expected results and higher outlook should support sentiment, while execution and cybersecurity remain key risks to monitor
Similar Companies in Healthcare
Other companies in the same sector with AI ratings